
Results
2
2 companies
Hyloris Pharmaceuticals
Market Cap: €155.7m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.56
7D
-7.0%
1Y
-10.9%
argenx
Market Cap: €36.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€588.20
7D
-4.6%
1Y
4.1%